These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15385355)

  • 1. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.
    Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
    Anesth Analg; 2004 Oct; 99(4):1086-1089. PubMed ID: 15385355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cisatracurium on morbidly obese women.
    Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
    Anesth Analg; 2004 Oct; 99(4):1090-1094. PubMed ID: 15385356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.
    Pühringer FK; Khuenl-Brady KS; Mitterschiffthaler G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():107-10. PubMed ID: 8556996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of tracheal intubation conditions in morbidly obese patients: a comparison of succinylcholine and rocuronium].
    de Almeida MC; Pederneiras SG; Chiaroni S; de Souza L; Locks GF
    Rev Esp Anestesiol Reanim; 2009 Jan; 56(1):3-8. PubMed ID: 19284121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients.
    Van Lancker P; Dillemans B; Bogaert T; Mulier JP; De Kock M; Haspeslagh M
    Anaesthesia; 2011 Aug; 66(8):721-5. PubMed ID: 21692760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients.
    Sakızcı-Uyar B; Çelik S; Postacı A; Bayraktar Y; Dikmen B; Özkoçak-Turan I; Saçan O
    Saudi Med J; 2016 Jan; 37(1):60-5. PubMed ID: 26739976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In non-obese patients, duration of action of rocuronium is directly correlated with body mass index.
    Fujimoto M; Tanahira C; Nishi M; Yamamoto T
    Can J Anaesth; 2013 Jun; 60(6):552-6. PubMed ID: 23463483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of rocuronium bromide in obese female patients.
    Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
    Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended duration of action of rocuronium in postpartum patients.
    Pühringer FK; Sparr HJ; Mitterschiffthaler G; Agoston S; Benzer A
    Anesth Analg; 1997 Feb; 84(2):352-4. PubMed ID: 9024027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of rocuronium in cholestatic patients with or without hepatocellular injury: normal onset time of initial dose and prolonged duration time after repeated doses.
    Yang JJ; Wang YG; Zhang Z; Zhang ZJ; Liu J; Xu JG
    J Pharm Pharm Sci; 2008; 11(3):15-21. PubMed ID: 18801303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics.
    van den Broek L; Wierda JM; Smeulers NJ; van Santen GJ; Leclercq MG; Hennis PJ
    J Clin Anesth; 1994; 6(4):288-96. PubMed ID: 7946364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saline Flush After Rocuronium Bolus Reduces Onset Time and Prolongs Duration of Effect: A Randomized Clinical Trial.
    Ishigaki S; Masui K; Kazama T
    Anesth Analg; 2016 Mar; 122(3):706-711. PubMed ID: 26599796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T; Szewczyk T; Gaszynski W
    Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
    Dragne A; Varin F; Plaud B; Donati F
    Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuromuscular effects of cisatracurium besylate in obese patients].
    Geng Z; Wu X
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2844-6. PubMed ID: 25534104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients.
    Matteo RS; Ornstein E; Schwartz AE; Ostapkovich N; Stone JG
    Anesth Analg; 1993 Dec; 77(6):1193-7. PubMed ID: 8250312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of rocuronium on the diaphragm, musculus adductor pollicis and orbicularis oculi in two groups of different age].
    Moerer O; Bittner J; Hinz J; Sydow M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Apr; 40(4):217-24. PubMed ID: 15832241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.